A detailed history of Stifel Financial Corp transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 17,064 shares of AUPH stock, worth $121,495. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,064
Previous 30,268 43.62%
Holding current value
$121,495
Previous $151,000 35.76%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.81 - $5.78 $63,511 - $76,319
-13,204 Reduced 43.62%
17,064 $97,000
Q1 2024

May 13, 2024

SELL
$4.93 - $9.31 $1.6 Million - $3.02 Million
-324,455 Reduced 91.47%
30,268 $151,000
Q4 2023

Feb 12, 2024

SELL
$7.13 - $9.49 $2,787 - $3,710
-391 Reduced 0.11%
354,723 $3.19 Million
Q3 2023

Nov 13, 2023

SELL
$7.77 - $12.27 $84,747 - $133,828
-10,907 Reduced 2.98%
355,114 $2.76 Million
Q2 2023

Aug 14, 2023

BUY
$8.96 - $11.69 $125,216 - $163,367
13,975 Added 3.97%
366,021 $3.54 Million
Q1 2023

May 12, 2023

BUY
$5.94 - $11.27 $163,130 - $309,508
27,463 Added 8.46%
352,046 $3.86 Million
Q4 2022

Feb 13, 2023

SELL
$4.11 - $8.14 $2.64 Million - $5.24 Million
-643,348 Reduced 66.47%
324,583 $1.4 Million
Q3 2022

Nov 14, 2022

SELL
$6.66 - $12.39 $490,215 - $911,978
-73,606 Reduced 7.07%
967,931 $7.28 Million
Q2 2022

Aug 15, 2022

SELL
$8.95 - $12.8 $3.36 Million - $4.81 Million
-375,416 Reduced 26.49%
1,041,537 $10.5 Million
Q1 2022

May 13, 2022

BUY
$10.05 - $22.48 $6.86 Million - $15.3 Million
682,793 Added 93.0%
1,416,953 $17.5 Million
Q4 2021

Feb 14, 2022

BUY
$17.78 - $33.08 $965,276 - $1.8 Million
54,290 Added 7.99%
734,160 $16.8 Million
Q3 2021

Nov 15, 2021

BUY
$10.93 - $23.55 $1.94 Million - $4.18 Million
177,655 Added 35.37%
679,870 $15 Million
Q2 2021

Aug 13, 2021

BUY
$10.0 - $14.52 $1.04 Million - $1.51 Million
104,206 Added 26.18%
502,215 $6.51 Million
Q1 2021

May 14, 2021

BUY
$12.3 - $18.73 $1.19 Million - $1.82 Million
96,943 Added 32.2%
398,009 $5.17 Million
Q4 2020

Feb 12, 2021

BUY
$12.94 - $16.05 $1.98 Million - $2.45 Million
152,638 Added 102.84%
301,066 $4.16 Million
Q3 2020

Nov 16, 2020

BUY
$13.19 - $16.66 $304,820 - $385,012
23,110 Added 18.44%
148,428 $2.19 Million
Q2 2020

Aug 14, 2020

BUY
$14.12 - $18.33 $896,281 - $1.16 Million
63,476 Added 102.64%
125,318 $2.04 Million
Q1 2020

May 14, 2020

BUY
$11.34 - $21.46 $139,005 - $263,056
12,258 Added 24.72%
61,842 $894,000
Q4 2019

Feb 13, 2020

BUY
$3.88 - $21.42 $25,503 - $140,793
6,573 Added 15.28%
49,584 $1 Million
Q3 2019

Nov 13, 2019

BUY
$5.34 - $6.59 $10,156 - $12,534
1,902 Added 4.63%
43,011 $231,000
Q2 2019

Aug 14, 2019

SELL
$6.05 - $6.75 $32,736 - $36,524
-5,411 Reduced 11.63%
41,109 $271,000
Q1 2019

May 14, 2019

BUY
$6.06 - $7.64 $21,331 - $26,892
3,520 Added 8.19%
46,520 $303,000
Q4 2018

Feb 13, 2019

SELL
$5.08 - $6.83 $11,155 - $14,998
-2,196 Reduced 4.86%
43,000 $295,000
Q3 2018

Nov 13, 2018

BUY
$5.27 - $6.64 $17,802 - $22,429
3,378 Added 8.08%
45,196 $300,000
Q2 2018

Aug 14, 2018

BUY
$5.06 - $6.36 $101,705 - $127,836
20,100 Added 92.55%
41,818 $236,000
Q1 2018

May 11, 2018

BUY
$4.85 - $5.99 $52,244 - $64,524
10,772 Added 98.41%
21,718 $113,000
Q4 2017

Feb 14, 2018

BUY
$4.53 - $7.09 $49,585 - $77,607
10,946
10,946 $49,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.01B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.